| Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis JG Scott, G Sedor, P Ellsworth, JA Scarborough, KA Ahmed, DE Oliver, ... The Lancet Oncology 22 (9), 1221-1229, 2021 | 99 | 2021 |
| UV sterilization of personal protective equipment with idle laboratory biosafety cabinets during the Covid-19 pandemic Theory Division, KJ Card, D Crozier, A Dhawan, MN Dinh, E Dolson, ... MedRxiv, 2020.03. 25.20043489, 2020 | 66 | 2020 |
| Personalizing radiotherapy prescription dose using genomic markers of radiosensitivity and normal tissue toxicity in NSCLC JG Scott, G Sedor, JA Scarborough, MW Kattan, J Peacock, GD Grass, ... Journal of Thoracic Oncology 16 (3), 428-438, 2021 | 46 | 2021 |
| UV decontamination of personal protective equipment with idle laboratory biosafety cabinets during the COVID-19 pandemic DT Weaver, BD McElvany, V Gopalakrishnan, KJ Card, D Crozier, ... PLoS One 16 (7), e0241734, 2021 | 40 | 2021 |
| Evolution of the ability to modulate host chemokine networks via gene duplication in human cytomegalovirus (HCMV) JA Scarborough, JR Paul, JV Spencer Infection, Genetics and Evolution 51, 46-53, 2017 | 30 | 2017 |
| Identifying States of Collateral Sensitivity during the Evolution of Therapeutic Resistance in Ewing's Sarcoma JA Scarborough, E McClure, P Anderson, A Dhawan, A Durmaz, ... Iscience 23 (7), 2020 | 26 | 2020 |
| SLX4IP promotes RAP1 SUMOylation by PIAS1 to coordinate telomere maintenance through NF-κB and Notch signaling NJ Robinson, M Miyagi, JA Scarborough, JG Scott, DJ Taylor, ... Science signaling 14 (689), eabe9613, 2021 | 18 | 2021 |
| Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma DT Weaver, KI Pishas, D Williamson, J Scarborough, SL Lessnick, ... PLoS Computational Biology 17 (10), e1008755, 2021 | 10 | 2021 |
| Revisiting a null hypothesis: exploring the parameters of oligometastasis treatment JA Scarborough, MC Tom, MW Kattan, JG Scott International Journal of Radiation Oncology* Biology* Physics 110 (2), 371-381, 2021 | 9 | 2021 |
| UV Sterilization of Personal Protective Equipment with Idle Laboratory Biosafety Cabinets During the Covid-19 Pandemic (preprint) DT Weaver, BD McElvany, V Gopalakrishnan, KJ Card, D Crozier, ... | 9 | 2020 |
| Identifying states of collateral sensitivity during the evolution of therapeutic resistance in Ewing’s sarcoma. iScience. 2020 JA Scarborough, E McClure, P Anderson, A Dhawan, A Durmaz, ... | 7 | |
| Evolution-informed strategies for combating drug resistance in cancer K Lin-Rahardja, DT Weaver, JA Scarborough, JG Scott International Journal of Molecular Sciences 24 (7), 6738, 2023 | 5 | 2023 |
| Hearing loss patterns in enlarged vestibular aqueduct syndrome: Do fluctuations have clinical significance? JS Ruthberg, A Kocharyan, N Farrokhian, MC Stahl, K Hicks, ... International Journal of Pediatric Otorhinolaryngology 156, 111072, 2022 | 5 | 2022 |
| Translation of precision medicine research into biomarker-informed care in radiation oncology JA Scarborough, JG Scott Seminars in radiation oncology 32 (1), 42-53, 2022 | 5 | 2022 |
| Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature JA Scarborough, SA Eschrich, J Torres-Roca, A Dhawan, JG Scott NPJ Precision Oncology 7 (1), 38, 2023 | 2 | 2023 |
| Exploiting convergent evolution to derive a pan-cancer cisplatin response gene expression signature JA Scarborough, SA Eschrich, J Torres-Roca, A Dhawan, JG Scott medRxiv, 2021.11. 10.21265799, 2021 | 2 | 2021 |
| GARD is a pan-cancer predictor of clinical outcome in radiation treated patients JG Scott, G Sedor, P Ellsworth, JA Scarborough, K Ahmed, SA Eschrich, ... medRxiv, 2020.12. 19.20248484, 2020 | 2 | 2020 |
| Stereotactic body radiation therapy for sarcoma pulmonary metastases W Asha, S Koro, Z Mayo, K Yang, A Halima, J Scott, J Scarborough, ... American Journal of Clinical Oncology 46 (6), 263-270, 2023 | 1 | 2023 |
| A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma L De Cecco, S Cavalieri, G Sedor, F Hoebers, R Brakenhoff, ... | | 2023 |
| A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma E Ho, L De Cecco, S Cavalieri, G Sedor, F Hoebers, RH Brakenhoff, ... medRxiv, 2023 | | 2023 |
Jacob G. Scott (he/him)Associate Professor and Staff Physician-Scientist, Translational Hematology and Oncology ResearchVerified email at ccf.org
